PERFORMANCE-ENHANCED PROTEASE VARIANTS I

DE502018015304D1Active Publication Date: 2024-11-28HENKEL KGAA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE502018015304
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-06-05
Filing Date
2018-09-05
Publication Date
2024-11-28
Estimated Expiration
2038-09-05

AI Technical Summary

Technical Problem

Existing proteases used in detergents and cleaning agents often lack sufficient catalytic activity and storage stability at standard washing temperatures (20°C to 40°C), resulting in suboptimal cleaning performance on protease-sensitive soils.

Method used

A protease from Bacillus pumilus with specific amino acid substitutions at positions 271, 9, and other positions, such as 18, 29, 48, 92, 101, 130, 131, 133, 144, 149, 156, 162, 166, 172, 192, 217, 224, and 252, enhancing proteolytic activity and storage stability.

Benefits of technology

The modified protease exhibits improved catalytic activity and storage stability, leading to enhanced cleaning performance on protease-sensitive soils, with activity levels exceeding 100% of wild-type proteases and maintaining stability for extended periods.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The invention lies in the field of enzyme technology. The invention relates to proteases from Bacillus pumilus, the amino acid sequence of proteases, which have been modified, particularly with regard to their use in detergents and cleaning agents, to improve their cleaning performance at low temperatures (e.g., between 20°C and 40°C), and the nucleic acids encoding them, as well as their production. The invention further relates to the uses of these proteases and processes in which they are used, as well as agents containing them, in particular detergents and cleaning agents.

[0002] Proteases are among the most technically important enzymes. They are the longest-established enzymes in detergents and cleaning agents and are found in virtually all modern, high-performance detergents and cleaning products. They break down protein-based soils on the items being cleaned. Of particular importance are subtilisin-type proteases (subtilases, subtilopeptidases, EC 3.4.21.62), which are serine proteases due to their catalytically active amino acids. They act as non-specific endopeptidases and hydrolyze any amide bonds located within peptides or proteins. Their optimum pH is usually in the strongly alkaline range. An overview of this family is provided, for example, by the article "Subtilases: subtilisin-like proteases" by R. Siezen, pages 75-95 in "Subtilisin enzymes", edited by R. Bott and C. Betzel, New York, 1996. subtilases are naturally produced by microorganisms.Among these, the subtilisins produced and secreted by Bacillus species are particularly noteworthy as the most important group within the subtilases.

[0003] Examples of subtilisin-type proteases preferably used in washing and cleaning agents are the subtilisins BPN' and Carlsberg, the protease PB92, the subtilisins 147 and 309, the protease from Bacillus lentus, especially from Bacillus lentusDSM 5483, subtilisin DY, and the enzymes thermitase, proteinase K, and the proteases TW3 and TW7, which are classified as subtilases but no longer as subtilisins in the strict sense, as well as variants of the aforementioned proteases that exhibit an altered amino acid sequence compared to the original protease, are considered to be modified. Proteases are modified using methods known from the prior art, either selectively or randomly, and thus optimized, for example, for use in detergents and cleaning agents. These methods include point mutagenesis, deletion or insertion mutagenesis, or fusion with other proteins or protein fragments. Accordingly, optimized variants are known for most proteases known from the prior art. For example, variants of savinase and / or BPN' are known from WO 2011 / 036263.

[0004] In EP 2016175 A1, WO 2017 / 198488 and WO 2017 / 162429, a protease intended for washing and cleaning agents is described. Bacillus pumilusThis has been revealed. Generally, only selected proteases are suitable for use in liquid surfactant-containing preparations. Many proteases do not exhibit sufficient catalytic performance in such preparations. Therefore, for the application of proteases in cleaning agents, high catalytic activity under conditions such as those encountered during a washing cycle and high storage stability are particularly desirable.

[0005] Consequently, prior art liquid formulations containing protease and surfactant have the disadvantage that the proteases contained do not exhibit satisfactory proteolytic activity under standard washing conditions (e.g. in a temperature range of 20°C to 40°C) or are not stable in storage, and therefore the formulations do not show optimal cleaning performance on protease-sensitive soils.

[0006] Surprisingly, it has now been discovered that a protease from Bacillus pumilusor a sufficiently similar protease (with respect to sequence identity) that has amino acid substitutions at positions corresponding to positions 271 and 9, respectively, with respect to the numbering according to SEQ ID NO:1, and at least one of the positions corresponding to positions 18, 29, 48, 61, 92, 101, 130, 131, 133, 137, 144, 149, 156, 162, 166, 172, 192, 217, 224, 252 or 265, respectively, with respect to the numbering according to SEQ ID NO:1, and which has improved proteolytic activity under standard washing conditions compared to the wild type form and / or reference mutants and is therefore particularly suitable for use in washing or cleaning agents.

[0007] The invention therefore relates, in a first aspect, to a protease according to claim 1, comprising an amino acid sequence which has at least 90% sequence identity with the amino acid sequence specified in SEQ ID NO:1 over its total length and which, in each case, has the following numbering according to SEQ ID NO:1: (a) at the position corresponding to position 271, the amino acid substitution 271E; and (b) at the position corresponding to position 9, an amino acid substitution selected from 9T, 9H, 9S and 9A, preferably 9T; and (c1) at at least one of the positions corresponding to positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217 or 265, at least one further amino acid substitution selected from 18D, 61Y, 92S, 99Y, 137K, 1491, 156G, 156Y, 1591, 162S, 166M, 172G, 172P, 192V, 199M, 217M and 265A; and / or (c2) at at least three of the positions corresponding to positions 29, 48, 101, 130, 131, 133, 144, 217, 224 and 252, in particular 130, 133, 144, 217 and 252, at least three further amino acid substitutions selected from 29G, 48V, 101E, 130D, 130S, 130H, 131D, 131N, 131S, 131K, 133K, 133R, 133Y, 144K, 144L, 144A, 224A, 224T, 252S and 252T.

[0008] Another object of the invention is a method for producing a protease as defined above.

[0009] A protease within the meaning of the present patent application therefore comprises both the protease as such and a protease produced by a process according to the invention. All descriptions of the protease thus refer to both the protease as such and to the proteases produced by corresponding processes. The proteases described herein have features (a) and (b) and either (c1) or (c2) or (a), (b), (c1) and (c2).

[0010] Further aspects of the invention relate to the nucleic acids encoding these proteases, non-human host cells containing proteases according to the invention or nucleic acids, as well as agents comprising proteases according to the invention, in particular washing and cleaning agents, washing and cleaning processes, and uses of the proteases according to the invention in washing or cleaning agents for the removal of protein-containing soiling.

[0011] "At least one", as used herein, meant one or more, i.e. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or more.

[0012] If the protease is defined herein as comprising "the amino acid substitutions 9T, 9H, 9S, or 9A," this means that position 9 is mutated to either T, H, S, or A. The expression that the protease comprises "the amino acid substitutions 9T, 9H, 9S, or 9A and 271E, and optionally 216C" thus means that position 9 is mutated to either T, H, S, or A, position 271 to E, and position 216 optionally to C.

[0013] The present invention is based on the inventors' surprising discovery that amino acid substitutions at the positions described herein result in improved performance of this modified protease (proteolytic activity under standard washing conditions) in detergents and cleaning agents. Optionally, improved storage stability of this modified protease in detergents and cleaning agents can also be achieved. This is particularly surprising because none of the aforementioned amino acid substitutions had previously been associated with increased catalytic activity and / or increased storage stability of the protease.

[0014] In preferred embodiments of the protease according to the invention, the protease exhibits amino acid substitutions. (A) (i) at the positions corresponding to positions 9, 130, 133 and 271, each with reference to the numbering in SEQ ID NO:1, and optionally (ii) at at least one of the positions corresponding to positions 29, 48, 101, 131, 144, 224 or 252, each with reference to the numbering in SEQ ID NO:1; (B) (i) at the positions corresponding to positions 9, 130, 144 and 271, each with reference to the numbering in SEQ ID NO:1, and optionally (ii) at at least one of the positions corresponding to positions 29, 48, 101, 131, 133, 224 or 252, each with reference to the numbering in SEQ ID NO:1; (C) (i) at the positions corresponding to positions 9, 130, 252 and 271, each with reference to the numbering according to SEQ ID NO:1, and optionally (ii) at least one of the positions corresponding to positions 29, 48, 101, 131, 133, 144 or 224, each with reference to the numbering according to SEQ ID NO:1;(D) (i) at the positions corresponding to positions 9, 133, 144 and 271, each with reference to the numbering according to SEQ ID NO:1, and optionally (ii) at at least one of the positions corresponding to positions 29, 48, 101, 130, 131, 224 or 252, each with reference to the numbering according to SEQ ID NO:1; (E) (i) at the positions corresponding to positions 9, 133, 252 and 271, each with reference to the numbering according to SEQ ID NO:1, and optionally (ii) at at least one of the positions corresponding to positions 29, 48, 101, 130, 131, 144 or 224, each with reference to the numbering according to SEQ ID NO:1; (F) at the positions corresponding to positions 9, 144, 252 and 271, each with reference to the numbering according to SEQ ID NO:1, and optionally (ii) at least one of the positions corresponding to positions 29, 48, 101, 130, 131, 133 or 224, each with reference to the numbering according to SEQ ID NO:1;(G) at the positions corresponding to positions 9, 130, 144, 252 and 271, each with reference to the numbering according to SEQ ID NO:1, and optionally (ii) at at least one of the positions corresponding to positions 29, 48, 101, 131, 133, or 224, each with reference to the numbering according to SEQ ID NO:1; (H) at the positions corresponding to positions 9, 133, 144, 252 and 271, each with reference to the numbering according to SEQ ID NO:1, and optionally (ii) at at least one of the positions corresponding to positions 29, 48, 101, 130, 131, or 224, each with reference to the numbering according to SEQ ID NO:1; (I) at the positions corresponding to positions 9, 130, 133, 252 and 271, each with reference to the numbering according to SEQ ID NO:1, and optionally (ii) at least one of the positions corresponding to positions 29, 48, 101, 131, 144 or 224, each with reference to the numbering according to SEQ ID NO:1;(J) at the positions corresponding to positions 9, 130, 133, 144, and 271, each with reference to the numbering in SEQ ID NO:1, and optionally (ii) at at least one of the positions corresponding to positions 29, 48, 101, 131, 224, or 252, each with reference to the numbering in SEQ ID NO:1; or (K) at the positions corresponding to positions 9, 130, 133, 144, 252, and 271, each with reference to the numbering in SEQ ID NO:1, and optionally (ii) at at least one of the positions corresponding to positions 29, 48, 101, 131, or 224, each with reference to the numbering in SEQ ID NO:1.

[0015] In further embodiments, preferred proteases are those with amino acid substitutions at the following positions: 9 and 271, and at least one of 131, 133, 224, 130 and 144, and optionally at least one of 29, 48, 101 and 252; 9 + 271 + 131 + 224, and optionally at least one of 29, 48, 101, 130, 133, 144 or 252; 9 + 271 + 131 + 133, and optionally at least one of 29, 48, 101, 130, 144, 224 or 252; 9 + 271 + 131 + 133 + 224, and optionally at least one of 29, 48, 101, 130, 144 or 252; or 9 + 271 + 131 + 133 + 224 + 130 and optionally at least one of 29, 48, 101, 144 or 252;

[0016] In various embodiments, the protease exhibits (1) at the position corresponding to position 271, an amino acid substitution, in particular the amino acid substitution 271E; and (2-1) at the positions corresponding to positions 9, 130, 144 and 252, the amino acid substitutions 9T, 130D, 144K and 252T; and / or (2-2) at one or more of the positions corresponding to positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217 or 265, one or more amino acid substitutions selected from: 18D, 61Y, 92S, 99Y, 137K, 1491, 156G, 156Y, 159I, 162S, 166M, 172G, 172P, 192V, 199M, 217M and 265A; Feature (1) can be combined with feature (2-1), feature (2-2) or both.

[0017] In various embodiments, the protease has an amino acid substitution at the position corresponding to position 271, in particular the amino acid substitution 271E; and at the positions corresponding to positions 9, 130, 144 and 252, the amino acid substitutions 9T, 130D, 144K and 252T; and optionally at one or more of the positions corresponding to positions 62, 99, 133, 137, 149, 156, 162, 166, 172, 192, 199, 217, 224 or 265, at least one, for example 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13, for example 1, 2, 3 or 4, further amino acid substitution(ies), wherein these are preferably selected from: 62S, 99Y, 133R, 133K, 133A, 137K, 149I, 156G, 156Y, 162S, 166M, 172G, 172P, 192V, 199M, 217M, 224A and 265A. Such proteases are disclosed, for example, in Example 1 and are thus part of the invention.Particularly preferred are proteases having an amino acid substitution, in particular the amino acid substitution 271E, at the position corresponding to position 271; and having the amino acid substitutions 9T, 130D, 144 and 252T at the positions corresponding to positions 9, 130, 144 and 252; and optionally at one or more of the positions corresponding to positions 62, 133, 137, 162, 192, 217 or 265, at least one, for example 1, 2, 3, 4, 5, 6 or 7, for example 1, 2, 3 or 4 further amino acid substitution(s), wherein these are preferably selected from: 62S, 133R, 133K, 133A, 137K, 162S, 192V, 217M and 224A.

[0018] In further embodiments, the protease has amino acid substitutions at the following positions (in the numbering according to SEQ ID NO:1): 9 + 271 + 29 + 48 + 101 9 + 271 + 29 + 48 + 130 9 + 271 + 29 + 48 + 131 9 + 271 + 29 + 48 + 133 9 + 271 + 29 + 48 + 144 9 + 271 + 29 + 48 + 224 9 + 271 + 29 + 48 + 252 9 + 271 + 29 + 101 + 130 9 + 271 + 29 + 101 + 131 9 + 271 + 29 + 101 + 133 9 + 271 + 29 + 101 + 144 9 + 271 + 29 + 101 + 224 9 + 271 + 29 + 101 + 252 9 + 271 + 29 + 130 + 131 9 + 271 + 29 + 130 + 133 9 + 271 + 29 + 130 + 144 9 + 271 + 29 + 130 + 224 9 + 271 + 29 + 130 + 252 9 + 271 + 29 + 131 + 133 9 + 271 + 29 + 131 + 144 9 + 271 + 29 + 131 + 224 9 + 271 + 29 + 131 + 252 The following are selected: 62S, 99Y, 133R, 133K, 133A, 137K, 149I, 156G, 156Y, 162S, 166M, 172G, 172P, 192V, 199M, 217M, 224A, and 265A. Such proteases are disclosed, for example, in Example 1 and are thus part of the invention. Particularly preferred are those proteases which, at the position corresponding to position 271, have an amino acid substitution, in particular the amino acid substitution 271E; and at the positions corresponding to positions 9, 130, 144, and 252, have the amino acid substitutions 9T, 130D, 144K, and 252T. and optionally at one or more of the positions corresponding to positions 62, 133, 137, 162, 192, 217 or 265, at least one, for example 1, 2, 3, 4, 5, 6 or 7, for example 1, 2, 3 or 4 further amino acid substitution(s), wherein these are preferably selected from: 62S, 133R, 133K, 133A, 137K, 162S, 192V, 217M and 224A.

[0019] In further embodiments, the protease has amino acid substitutions at the following positions (in the numbering according to SEQ ID NO:1): 9 + 271 + 29 9 + 271 + 48 9 + 271 + 101 9 + 271 + 130 9 + 271 + 131 9 + 271 + 133 9 + 271 + 144 9 + 271 + 224 9 + 271 + 252 9 + 271 + 29 + 48 9 + 271 + 29 + 101 9 + 271 + 29 + 130 9 + 271 + 29 + 131 9 + 271 + 29 + 133 9 + 271 + 29 + 144 9 + 271 + 29 + 224 9 + 271 + 29 + 252 9 + 271 + 48 + 101 9 + 271 + 48 + 130 9 + 271 + 48 + 131 9 + 271 + 48 + 133 9 + 271 + 48 + 144 9 + 271 + 48 + 224 9 + 271 + 48 + 252 9 + 271 + 101 + 130 9 + 271 + 101 + 131 9 + 271 + 101 + 133 9 + 271 + 101 + 144 9 + 271 + 101 + 224 9 + 271 + 101 + 252 9 + 271 + 130 + 131 9 + 271 + 130 + 133 9 + 271 + 130 + 144 9 + 271 + 130 + 224 9 + 271 + 130 + 252 9 + 271 + 131 + 133 9 + 271 + 131 + 144 9 + 271 + 131 + 224 9 + 271 + 131 + 252 9 + 271 + 133 + 144 9 + 271 + 133 + 224 9 + 271 + 133 + 252 9 + 271 + 144 + 224 9 + 271 + 144 + 252 9 + 271 + 224 + 252 9 + 271 + 29 + 48 + 101 9 + 271 + 29 + 48 + 130 9 + 271 + 29 + 48 + 131 9 + 271 + 29 + 48 + 133 9 + 271 + 29 + 48 + 144 9 + 271 + 29 + 48 + 224 9 + 271 + 29 + 48 + 252 9 +271 + 29 + 101 + 130 9 + 271 + 29 + 101 + 131 9 + 271 + 29 + 101 + 133 9 + 271 + 29 + 101 + 144 9 + 271 + 29 + 101 +224 9 + 271 + 29 + 101 +252 9+271 + 29 + 130 + 131 9 + 271 + 29 + 130 + 133 9 + 271 + 29 + 130 + 144 9 + 271 + 29 + 130 + 224 9 + 271 + 29 + 130 + 252 9 + 271 + 29 + 131 + 133 9 + 271 + 29 + 131 + 144 9 + 271 + 29 + 131 +224 9 + 271 + 29 + 131 +252 9 + 271 + 29 + 133 + 144 9 + 271 + 29 + 133 + 224 9 + 271 + 29 + 133 + 252 9 + 271 + 29 + 144 + 224 9 + 271 + 29 + 144 + 252 9 + 271 + 29 + 224 + 252 9 + 271 + 48 + 101 + 130 9 + 271 + 48 + 101 + 131 9 + 271 + 48 + 101 + 133 9 + 271 + 48 + 101 + 144 9 + 271 + 48 + 101 + 224 9 + 271 + 48 + 101 + 252 9 + 271 + 48 + 130 + 131 9 + 271 + 48 + 130 + 133 9 + 271 + 48 + 130 + 144 9 + 271 + 48 + 130 + 224 9 + 271 + 48 + 130 + 252 9 + 271 + 48 + 131 + 133 9 + 271 + 48 + 131 + 144 9 + 271 + 48 + 131 + 224 9 + 271 + 48 + 131 + 252 9 + 271 + 48 + 133 + 144 9 + 271 + 48 + 133 + 224 9 + 271 + 48 + 133 + 252 9 + 271 + 48 + 144 + 224 9 + 271 +48 + 144 + 252 9 + 271 + 48 + 224 + 252 9 + 271 + 101 + 130 + 131 9 + 271 + 101 + 130 + 133 9 + 271 + 101 + 130 + 144 9 + 271 + 101 + 130 + 224 9 + 271 + 101 + 130 + 252 9 + 271 + 101 + 131 + 133 9 + 271 + 101 + 131 + 144 9 + 271 + 101 + 131 + 224 9 + 271 + 101 + 131 + 252 9 + 271 + 101 + 133 + 144 9 + 271 + 101 + 133 + 224 9 + 271 + 101 + 133 + 252 9 + 271 + 101 + 144 + 224 9 + 271 + 101 + 144 + 252 9 + 271 + 101 + 224 + 252 9 + 271 + 130 + 131 + 133 9 + 271 + 130 + 131 + 144 9 + 271 + 130 + 131 + 224 9 + 271 + 130 + 131 + 252 9 + 271 + 130 + 133 + 144 9 + 271 + 130 + 133 + 224 9 + 271 + 130 + 133 + 252 9 + 271 + 130 + 144 + 224 9 + 271 + 130 + 144 + 252 9 + 271 + 130 + 224 + 252 9 + 271 + 131 + 133 + 144 9 + 271 + 131 + 133 + 224 9 + 271 + 131 + 133 + 252 9 + 271 + 131 + 144 + 224 9 + 271 + 131 + 144 + 252 9 + 271 + 131 + 224 + 252 9 + 271 + 133 + 144 + 224 9 + 271 + 133 + 144 + 252 9 + 271 + 133 + 224 + 252 9 + 271 + 144 + 224 + 252 9 + 271 + 29 + 48 + 101 + 130 9 + 271 + 29 + 48 +101 + 131 9 + 271 + 29 + 48 + 101 + 133 9 + 271 + 29 + 48 + 101 + 144 9 + 271 + 29 +48 + 101 + 224 9 + 271 + 29 +48 + 101 + 252 9 + 271 + 29 + 48 + 130 + 131 9 + 271 + 29 + 48 + 130 + 133 9 + 271 + 29 + 48 + 130 + 144 9 + 271 + 29 + 48 + 130 + 224 9 + 271 + 29 + 48 + 130 + 252 9 + 271 + 29 + 48 + 131 + 133 9 + 271 + 29 + 48 + 131 + 144 9 + 271 + 29 + 48 + 131 + 224 9 + 271 + 29 + 48 + 131 + 252 9 + 271 + 29 + 48 + 133 + 144 9 + 271 + 29 + 48 + 133 + 224 9 + 271 + 29 + 48 + 133 + 252 9 + 271 + 29 + 101 + 130 + 131 9 + 271 + 29 + 101 + 130 + 133 9 + 271 + 29 + 101 + 130 + 144 9 + 271 + 29 + 101 + 130 + 224 9 + 271 + 29 + 101 + 130 + 252 9 + 271 + 29 + 101 + 131 + 133 9 + 271 + 29 + 101 + 131 + 144 9 + 271 + 29 + 101 + 131 + 224 9 + 271 + 29 + 101 + 131 + 252 9 + 271 + 29 + 101 + 133 + 144 9 + 271 + 29 + 101 + 133 + 224 9 + 271 + 29 + 101 + 133 + 252 9 + 271 + 29 + 101 + 144 + 224 9 + 271 + 29 + 101 + 144 + 252 9 + 271 + 29 + 101 + 224 + 252 9 + 271 + 29 + 130 + 131 + 133 9 + 271 + 29 +130 + 131 + 144 9 + 271 + 29 + 130 + 131 + 224 9 + 271 + 29 + 130 + 131 + 252 9 + 271 + 29 + 130 + 133 + 144 9 + 271 + 29 + 130 + 133 + 224 9 + 271 + 29 + 130 + 133 +252 9 + 271 + 29 + 130 + 144 + 224 9 + 271 + 29 + 130 + 144 + 252 9 + 271 + 29 + 130 + 224 + 252 9 + 271 + 29 + 131 + 133 + 144 9 + 271 + 29 + 131 + 133 + 224 9 + 271 + 29 + 131 + 133 + 252 9 + 271 + 29 + 131 + 144 + 224 9 + 271 + 29 + 131 + 144 + 252 9 + 271 + 29 + 131 + 224 + 252 9 + 271 + 29 + 133 + 144 + 224 9 + 271 + 29 + 133 + 144 + 252 9 + 271 + 29 + 133 + 224 + 252 9 + 271 + 29 + 144 + 224 + 252 9 + 271 + 48 + 101 + 130 + 131 9 + 271 + 48 + 101 + 130 + 133 9 + 271 + 48 + 101 + 130 + 144 9 + 271 + 48 + 101 + 130 + 224 9 + 271 + 48 + 101 + 130 + 252 9 + 271 + 48 + 101 + 131 + 133 9 + 271 + 48 + 101 + 131 + 144 9 + 271 + 48 + 101 + 131 + 224 9 + 271 + 48 + 101 + 131 + 252 9 + 271 + 48 + 101 + 133 + 144 9 + 271 + 48 + 101 + 133 + 224 9 + 271 + 48 + 101 + 133 + 252 9 + 271 + 48 + 101 + 144 + 224 9 + 271 + 48 + 101 + 144+ 252 9 + 271 + 48 + 101 + 224 +252 9 + 271 + 48 + 130 + 131 + 133 9 + 271 + 48 + 130 + 131 + 144 9 + 271 + 48 + 130 + 131 + 224 9 + 271 + 48 + 130 + 131 + 252 9 + 271 + 48 + 130 + 133 + 144 9 + 271 + 48 + 130 + 133 + 224 9 + 271 + 48 + 130 + 133 + 252 9 + 271 + 48 + 130 + 144 + 224 9 + 271 + 48 + 130 + 144 + 252 9 + 271 + 48 + 130 + 224 + 252 9 + 271 + 48 + 131 + 133 + 144 9 + 271 + 48 + 131 + 133 + 224 9 + 271 + 48 + 131 + 133 + 252 9 + 271 + 48 + 131 + 144 + 224 9 + 271 + 48 + 131 + 144 + 252 9 + 271 + 48 + 131 + 224 + 252 9 + 271 + 48 + 133 + 144 + 224 9 + 271 + 48 + 133 + 144 + 252 9 + 271 + 48 + 133 + 224 + 252 9 + 271 + 48 + 144 + 224 + 252 9 + 271 + 101 + 130 + 131 + 133 9 + 271 + 101 + 130 + 131 + 144 9 + 271 + 101 + 130 + 131 + 224 9 + 271 + 101 + 130 + 131 + 252 9 + 271 + 101 + 130 + 133 + 144 9 + 271 + 101 + 130 + 133 + 224 9 + 271 + 101 + 130 + 133 + 252 9 + 271 + 101 + 130 + 144 + 224 9 + 271 + 101 + 130 + 144 + 252 9 + 271 + 101 + 130 + 224 + 252 9 + 271 + 101 + 131 +133 + 144 9 + 271 + 101 + 131 + 133 + 224 9 + 271 + 101 + 131 + 133 + 252 9 + 271 + 101 + 131 + 144 + 224 9 + 271 + 101 + 131 + 144 + 252 9 + 271 + 101 + 131 + 224 + 252 9 + 271 + 101 + 133 + 144 + 224 9 + 271 + 101 + 133 + 144 + 252 9 + 271 + 101 + 133 + 224 + 252 9 + 271 + 101 + 144 + 224 + 252 9 + 271 + 130 + 131 + 133 + 144 9 + 271 + 130 + 131 + 133 + 224 9 + 271 + 130 + 131 + 133 + 252 9 + 271 + 130 + 131 + 144 + 224 9 + 271 + 130 + 131 + 144 + 252 9 + 271 + 130 + 131 + 224 + 252 9 + 271 + 130 + 133 + 144 + 224 9 + 271 + 130 + 133 + 144 + 252 9 + 271 + 130 + 133 + 224 + 252 9 + 271 + 130 + 144 + 224 + 252 9 + 271 + 131 + 133 + 144 + 224 9 + 271 + 131 + 133 + 144 + 252 9 + 271 + 131 + 133 + 224 + 252 9 + 271 + 131 + 144 + 224 + 252 9 + 271 + 133 + 144 + 224 + 252

[0020] In various embodiments, the aforementioned variants have no further substitutions or only one or more additional substitutions at positions from the group of positions 29, 48, 101, 130, 131, 133, 144, 224, and 252, insofar as these have not already been mentioned above. In further embodiments, in particular in all embodiments described above, the protease according to the invention has an additional amino acid substitution at the position corresponding to position 217, based on the numbering according to SEQ ID NO:1. This amino acid substitution can be amino acid substitution 217M. 271 + 92 271 + 99 271 + 137 271 + 149 271 + 156 271 + 159 271 + 162 271 + 166 271 + 172 271 + 192 271 + 199 271 + 217 271 + 265 271 + 18 + 61 271 + 18 + 92 271 + 18 + 99 271 + 18 + 137 271 + 18 + 149 271 + 18 + 156 271 + 18 + 159 271 + 18 + 162 271 + 18 + 166 271 + 18 + 172 271 + 18 + 192 271 + 18 + 199 271 + 18 + 217 271 + 18 + 265 271 + 61 + 92 271 + 61 + 99 271 + 61 + 137 271 + 61 + 149 271 + 61 + 156 271 + 61 + 159 271 + 61 + 162 271 + 61 + 166 271 + 61 + 172 271 + 61 + 192 271 + 61 + 199 271 + 61 + 217 271 + 61 + 265 271 + 92 + 99 271 + 92 + 137 271 + 92 + 149 271 + 92 + 156 271 + 92 + 159 271 + 92 + 162 271 + 92 + 166 271 + 92 + 172 271 + 92 + 192 271 + 92 + 199 271 + 92 + 217 271 + 92 + 265 271 + 99 + 137 271 + 99 + 149 271 + 99 + 156 271 + 99 + 159 271 + 99 + 162 271 + 99 + 166 271 + 99 + 172 271 + 99 + 192 271 + 99 + 199 271 + 99 + 217 271 + 99 + 265 271 + 137 + 149 271 + 137 + 156 271 + 137 + 159 271 + 137 + 162 271 + 137 + 166 271 + 137 + 172 271 + 137 + 192 271 + 137 + 199271 + 137 + 217 271 + 137 + 265 271 + 149 + 156 271 + 149 + 159 271 + 149 + 162 271 + 149 + 166 271 + 149 + 172 271 + 149 + 192 271 + 149 + 199 271 + 149 + 217 271 + 149 + 265 271 + 156 + 159 271 + 156 + 162 271 + 156 + 166 271 + 156 + 172 271 + 156 + 192 271 + 156 + 199 271 + 156 + 217 271 + 156 + 265 271 + 159 + 162 271 + 159 + 166 271 + 159 + 172 271 + 159 + 192 271 + 159 + 199 271 + 159 + 217 271 + 159 + 265 271 + 162 + 166 271 + 162 + 172 271 + 162 + 192 271 + 162 + 199 271 + 162 + 217 271 + 162 + 265 271 + 166 + 172 271 + 166 + 192 271 + 166 + 199 271 + 166 + 217 271 + 166 + 265 271 + 172 + 192 271 + 172 + 199 271 + 172 + 217 271 + 172 + 265 271 + 192 + 199 271 + 192 + 217 271 + 192 + 265 271 + 199 + 217 271 + 199 + 265 271 + 217 + 265

[0021] In various embodiments, the aforementioned variants have no further substitutions or only one or more additional substitutions in the positions from the group of positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217 and 265, insofar as these have not already been mentioned above.

[0022] In all the aforementioned variants, the corresponding replacements are in particular those mentioned above, i.e. 9T, 9H, 9S, 9A, 29G, 48V, 101E, 130D, 130S, 130H, 131D, 131N, 131S, 131K, 133K, 133R, 133Y, 144K, 144L, 144A, 224A, 224T, 252S, 252T and / or 271E. Particularly preferred are 9T, 130D, 133R / K, 144K, 252T / S and / or 271E, especially 9T, 130D, 133R / K, 144K, 252T and 271E or 9T, 130D, 133K, 144K, 252T and 271E. Accordingly, the variants mentioned above in which the aforementioned substitutions occur are particularly preferred. A variant comprising the substitutions 9T, 130D, 144K, 252T and 271E, and optionally also 133R / K and / or 217M, is further preferred.

[0023] In preferred embodiments of the protease according to the invention, i.e., in particular the variants listed above, the protease has amino acid substitutions at the positions corresponding to positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217 or 265, which are selected from: 18D, 61Y, 92S, 99Y, 137K, 149I, 156G, 156Y, 159I, 162S, 166M, 172G, 172P, 192V, 199M, 217M and 265A.

[0024] In further embodiments, particularly in all embodiments described above, the protease according to the invention has an additional amino acid substitution at the position corresponding to position 216, based on the numbering according to SEQ ID NO: 1. This amino acid substitution can be the amino acid substitution S216C. However, in various preferred embodiments, the application described herein also relates to protease variants that do not have the substitution 216C, in particular no substitution at position 216 in the numbering according to SEQ ID NO: 1.

[0025] The protease according to the invention contains, in various embodiments, at least one amino acid substitution selected from the group consisting of A29G, A48V, D101E, N130D, N130S, N130H, G131D, G131N, G131S, G131K, T133K, T133R, T133Y, N144K, N144L, N144A, S224A, S224T or N252S, each with reference to the numbering according to SEQ ID NO: 1.In further preferred embodiments, the protease according to the invention contains the amino acid substitutions (1) P9T, P9H, P9S or P9A and (2) Q271E and optionally also (3) S216C as well as additionally one of the following amino acid substitution variants: (I) A48V, G131S, T133R and S224A; (II) G131D, T133R and S224A; (III) N130D, G131N, T133K and N144K; (IV) A29G, N130D, G131N and T133R; (V) N130D, G131S, T133K and S224A; (VI) N130D, G131N, T133K, N144L and N252S; (VII) G131S, N144K and S224T; (VIII) N130S, G131S, T133Y, N144L and S224A; (IX) D101E, G131N and S224A; or (X) N130H, G131S and S224A, the numbering in each case referring to the numbering according to SEQ ID NO: 1.

[0026] In various embodiments, the proteases have an amino acid sequence according to one of the SEQ ID Nos. 3-12, 16-25 or 15-25.

[0027] The proteases according to the invention typically exhibit improved cleaning performance, i.e., increased catalytic activity in detergents or cleaning agents. In various embodiments, the proteases according to the invention can possess a proteolytic activity that, relative to the wild type (SEQ ID NO:1), is at least 101%, preferably at least 102% or more. In various embodiments, the proteases according to the invention possess a proteolytic activity that, relative to a reference mutation variant of the protease (SEQ ID NO:13 and / or SEQ ID NO:2 and / or SEQ ID NO:14), is at least 110%, at least 115%, at least 120%, at least 125%, at least 130%, at least 135%, at least 140%, at least 145%, at least 150%, at least 155%, or at least 160%.Such performance-enhanced proteases enable improved washing results on proteolytically sensitive soils in various temperature ranges, especially a temperature range of 20°C to 40°C.

[0028] The proteases according to the invention can exhibit increased storage stability in washing or cleaning agents, independently of or in addition to their increased cleaning performance. This means that, compared to the wild-type enzyme and especially also compared to the original variant or a reference mutation variant of the protease (SEQ ID NO: 2, 13 or 14), they can exhibit increased stability in washing or cleaning agents, particularly during storage of 3 or more days, 4 or more days, 7 or more days, 10 or more days, 12 or more days, 14 or more days, 21 or more days or 28 or more days.

[0029] The proteases according to the invention exhibit enzymatic activity, meaning they are capable of hydrolyzing peptides and proteins, particularly in a detergent or cleaning agent. A protease according to the invention is therefore an enzyme that catalyzes the hydrolysis of amide / peptide bonds in protein / peptide substrates and is thus able to cleave proteins or peptides. Furthermore, a protease according to the invention is preferably a mature protease, i.e., the catalytically active molecule without signal and / or propeptide(s). Unless otherwise specified, the given sequences also refer to mature (processed) enzymes.

[0030] In various embodiments of the invention, the protease is a free enzyme. This means that the protease can interact directly with all components of a composition and, if the composition is a liquid, that the protease is in direct contact with the solvent of the composition (e.g., water). In other embodiments, a composition may contain proteases that form an interaction complex with other molecules or that contain a "coating." In this case, a single or multiple protease molecules may be separated from the other components of the composition by a surrounding structure. Such a separating structure can be, but is not limited to, vesicles, such as a micelle or a liposome. The surrounding structure may also be a virus particle, a bacterial cell, or a eukaryotic cell. In various embodiments, a composition may contain cells of Bacillus pumilus or Bacillus subtilis,which express the proteases according to the invention, or contain cell culture supernatants of such cells.

[0031] In various embodiments of the invention, the protease comprises an amino acid sequence that is identical to the amino acid sequence specified in SEQ ID NO:1 over its total length to at least 90%, 90.5%, 91%, 91.5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5% and 98.8%, and in each case has the amino acid substitutions specified above with reference to the numbering according to SEQ ID NO:1. In the context of the present invention, the feature that a protease has the specified substitutions means that it contains one (of the specified) substitution(ies) at the respective position, i.e., at least the specified positions are not otherwise mutated or deleted, for example, by fragmentation of the protease. The amino acid sequences of exemplary proteases covered by the invention are given in SEQ ID Nos: 3-12 and 16-25 and 17-25, respectively.In various embodiments, the proteases described herein, with the exception of the explicitly mentioned substitutions, have the sequence of SEQ ID NO:1, i.e., apart from the substituted positions, they are 100% identical to the sequence according to SEQ ID NO:1.

[0032] The identity of nucleic acid or amino acid sequences is determined by sequence comparison. This sequence comparison is based on the established and commonly used BLAST algorithm (see, for example, Altschul et al. (1990): "Basic local alignment search tool", J. Mol. Biol. 215:403-410, and Altschul et al. (1997): "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", Nucleic Acids Res. 25:3389-3402) and is essentially performed by matching similar sequences of nucleotides or amino acids in the nucleic acid or amino acid sequences. A tabular assignment of the relevant positions is called an alignment. Another algorithm available in the art is the FASTA algorithm. Sequence comparisons (alignments), especially multiple sequence comparisons, are performed using computer programs. The Clustal series, for example, is frequently used (see, for example, the Clustal series).for example Chenna et al. (2003): "Multiple sequence alignment with the Clustal series of programs", Nucleic Acid Res. 31:3497-3500), T-Coffee (cf. for example Notredame et al. (2000): "T-Coffee: A novel method for multiple sequence alignments", J. Mol. Biol. 302:205-217) or programs based on these.

[0033] The sequences are based on programs or algorithms. Furthermore, sequence comparisons (alignments) are possible using the computer program Vector NTI® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California, USA) with the predefined standard parameters, whose AlignX module for sequence comparisons is based on ClustalW. Unless otherwise specified, the sequence identity given herein is determined using the BLAST algorithm.

[0034] Such a comparison also allows for a statement about the similarity of the compared sequences to one another. This is usually expressed as percentage identity, that is, the proportion of identical nucleotides or amino acid residues at the same positions or positions corresponding to each other in an alignment. The broader concept of homology includes conserved amino acid substitutions in the analysis of amino acid sequences, i.e., amino acids with similar chemical activity, since these usually exert similar chemical activities within the protein. Therefore, the similarity of the compared sequences can also be expressed as percentage homology or percentage similarity. Identity and / or homology statements can be made for entire polypeptides or genes, or only for individual regions. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by similarities in the sequences.Such regions often exhibit identical functions. They can be small and comprise only a few nucleotides or amino acids. Often, such small regions perform essential functions for the overall activity of the protein. It can therefore be useful to refer to sequence similarities only for individual, possibly small, regions. Unless otherwise stated, however, statements of identity or homology in this application refer to the total length of the respective nucleic acid or amino acid sequence.

[0035] In the context of the present invention, the statement that an amino acid position corresponds to a numerically designated position in SEQ ID NO:1 therefore means that the corresponding position is assigned to the numerically designated position in SEQ ID NO: 1 in an alignment as defined above.

[0036] In a further embodiment of the invention, the protease is characterized in that its cleaning performance is not significantly reduced compared to that of a protease comprising an amino acid sequence corresponding to the amino acid sequence specified in SEQ ID NO:13 and / or SEQ ID NO:2 and / or SEQ ID NO:14, i.e., it possesses at least 80% of the reference washing performance, preferably at least 100%, and more preferably at least 110% or more. The cleaning performance can be determined in a washing system containing a detergent at a dosage between 4.5 and 7.0 grams per liter of wash liquor and the protease, wherein the proteases to be compared are used at the same concentration (based on active protein), and the cleaning performance relative to soiling on cotton is determined by measuring the degree of cleanliness of the washed textiles.

[0037] For example, the washing process can be carried out for 60 minutes at a temperature of 40°C, and the water can have a hardness between 15.5 and 16.5° (German hardness). The concentration of the protease in the detergent intended for this washing system is 0.001 to 0.1 wt.%, preferably 0.01 to 0.06 wt.%, based on active, purified protein.

[0038] A liquid reference detergent for such a washing system may be composed as follows (all values ​​in weight percent): 4.4% alkylbenzenesulfonic acid, 5.6% other anionic surfactants, 2.4% C12-C18 sodium salts of fatty acids (soaps), 4.4% non-ionic surfactants, 0.2% phosphonates, 1.4% citric acid, 0.95% sodium hydroxide, 0.01% defoamer, 2% glycerin, 0.08% preservatives, 1% ethanol, remainder demineralized water. Preferably, the dosage of the liquid detergent is between 4.5 and 6.0 grams per liter of wash liquor, for example, 4.7, 4.9, or 5.9 grams per liter of wash liquor. Washing is preferably carried out in a pH range between pH 7 and pH 10.5, preferably between pH 7.5 and pH 8.5.

[0039] Within the scope of the invention, the cleaning performance is determined, for example, at 20°C or 40°C using a liquid detergent as specified above, wherein the washing process preferably takes place for 60 minutes at 600 rpm.

[0040] The degree of whiteness, i.e., the lightening of the soiling, as a measure of cleaning performance, is determined using optical measurement methods, preferably photometrically. A suitable device for this purpose is, for example, the Minolta CM508d spectrometer. The devices used for the measurement are usually calibrated beforehand with a white standard, preferably one supplied with the device.

[0041] By using proteases with identical activity, it is ensured that even if the ratio of active substance to total protein (the specific activity values) differs, the respective enzymatic properties, such as the cleaning performance on specific types of soil, can be compared. Generally, a low specific activity can be compensated for by adding a larger amount of protein.

[0042] Otherwise, methods for determining protease activity are familiar to those skilled in the art in enzyme technology and are routinely used by them. For example, such methods are disclosed in Surfactants, Volume 7 (1970), pp. 125-132. Alternatively, the protease activity can be determined via the release of the chromophore para-nitroaniline (pNA) from the substrate suc-L-Ala-L-Ala-L-Pro-L-Phe-p-nitroanilide (AAPF). The protease cleaves the substrate and releases pNA. The release of pNA causes an increase in absorbance at 410 nm, the time course of which is a measure of the enzymatic activity (cf. Del Mar et al., 1979). The measurement is performed at a temperature of 25°C, pH 8.6, and a wavelength of 410 nm. The measurement time is 5 minutes and the measurement interval is 20 to 60 seconds. Protease activity is usually expressed in protease units (PE). Suitable protease activities are, for example, 2.25, 5, or 10 PE per ml of washing solution.However, protease activity is not zero.

[0043] An alternative test for determining the proteolytic activity of the proteases according to the invention is an optical measurement method, preferably a photometric method. The suitable test comprises the protease-dependent cleavage of the substrate protein casein. This is cleaved by the protease into a multitude of smaller subproducts. The totality of these subproducts exhibits increased absorption at 290 nm compared to uncleaved casein, whereby this increased absorption can be determined using a photometer, and thus a conclusion can be drawn about the enzymatic activity of the protease.

[0044] Protein concentration can be determined using known methods, for example the BCA method (bicinchoninic acid; 2,2'-biquinolyl-4,4'-dicarboxylic acid) or the biuret method (AG Gornall, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766). The determination of the active protein concentration can be carried out by titration of the active sites using a suitable irreversible inhibitor and determination of the residual activity (cf. M. Bender et al., J. Am. Chem. Soc. 88, 24 (1966), pp. 5890-5913).

[0045] In addition to the amino acid modifications described above, proteases according to the invention can exhibit further amino acid modifications, in particular amino acid substitutions, insertions, or deletions. Such proteases are further developed, for example, by targeted genetic modification, i.e., by mutagenesis techniques, and optimized for specific applications or with regard to special properties (e.g., their catalytic activity, stability, etc.). Furthermore, nucleic acids according to the invention can be introduced into recombination reactions and thus used to generate entirely novel proteases or other polypeptides.

[0046] The aim is to introduce targeted mutations, such as substitutions, insertions, or deletions, into known molecules in order to improve, for example, the cleaning performance of enzymes according to the invention. For this purpose, the surface charges and / or the isoelectric point of the molecules, and thus their interactions with the substrate, can be altered. For example, the net charge of the enzymes can be changed to influence substrate binding, particularly for use in detergents and cleaning agents. Alternatively or additionally, one or more corresponding mutations can increase the stability or catalytic activity of the protease and thereby improve its cleaning performance. Advantageous properties of individual mutations, such as individual substitutions, can be complementary.A protease that is already optimized with regard to certain properties, for example with regard to its stability during storage, can therefore be further developed within the scope of the invention.

[0047] For the description of substitutions affecting exactly one amino acid position (amino acid exchanges), the following convention is used: first, the naturally occurring amino acid is designated using the internationally accepted one-letter code, followed by the corresponding sequence position, and finally the inserted amino acid. Multiple exchanges within the same polypeptide chain are separated by slashes. In the case of insertions, additional amino acids are named after the sequence position. In the case of deletions, the missing amino acid is replaced by a symbol, such as an asterisk or a dash, or a Δ is indicated before the corresponding position.For example, P9T describes the substitution of proline at position 9 by threonine, P9TH the insertion of histidine after the amino acid threonine at position 9, P9* or ΔP9 the deletion of proline at position 9, and 130R / K the substitution at position 130 by lysine or arginine. This nomenclature is familiar to those skilled in the art in enzyme technology.

[0048] Another object of the invention is therefore a protease characterized in that it is obtainable from a protease as described above as a starting molecule by one or more conservative amino acid substitutions, wherein the protease, in the numbering according to SEQ ID NO:1, has the amino acid substitutions described above. The term "conservative amino acid substitution" means the exchange (substitution) of one amino acid residue for another amino acid residue, wherein this exchange does not lead to a change in polarity or charge at the position of the exchanged amino acid, e.g., the exchange of one nonpolar amino acid residue for another nonpolar amino acid residue. Conservative amino acid substitutions within the scope of the invention include, for example: G=A=S, I=V=L=M, D=E, N=Q, K=R, Y=F, S=T, G=A=I=V=L=M=Y=F=W=P=S=T.

[0049] Alternatively or additionally, the protease is characterized in that it is obtainable from a protease according to the invention as a starting molecule by fragmentation, deletion, insertion, or substitution mutagenesis and comprises an amino acid sequence that, over a length of at least 200, 210, 220, 230, 240, 250, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, or 274 contiguous amino acids, is identical to that of the starting molecule, wherein the amino acid substitution(ies) possibly contained in the starting molecule, as described herein according to the invention, are still present. That is, when the proteases described herein are modified, the modification is carried out in such a way that the substitutions according to the invention are retained.

[0050] Alternatively or additionally, the protease is characterized in that it is obtainable from a protease according to the invention as a starting molecule by fragmentation, deletion, insertion or substitution mutagenesis and comprises an amino acid sequence that corresponds to the starting molecule over a length of at least 200, 210, 220, 230, 240, 250, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273 or 274 contiguous amino acids, wherein the amino acid substitution(ies) possibly contained in the starting molecule, which are described herein according to the invention, are still present.

[0051] For example, it is possible to delete individual amino acids at the termini or in the loops of the enzyme without losing or reducing its proteolytic activity. Furthermore, such fragmentation, deletion, insertion, or substitution mutagenesis can, for instance, reduce the allergenicity of the enzymes in question and thus improve their overall usability. Advantageously, the enzymes retain their proteolytic activity even after mutagenesis; that is, their proteolytic activity is at least equal to that of the original enzyme. In a preferred embodiment, the proteolytic activity is at least 80%, preferably at least 90%, of the activity of the original enzyme. Further substitutions can also have beneficial effects. Both single and multiple contiguous amino acids can be exchanged for other amino acids.

[0052] Alternatively or additionally, the protease is characterized in that it can be obtained from a protease according to the invention as a starting molecule by one or more conservative amino acid substitutions, wherein the amino acid substitutions according to the invention remain unchanged.

[0053] The further amino acid positions are determined by an alignment of the amino acid sequence of a protease according to the invention with the amino acid sequence of the protease from Bacillus pumilus, as defined in SEQ ID NO:1. Furthermore, the assignment of positions is based on the mature protein. This assignment is particularly applicable when the amino acid sequence of a protease according to the invention comprises a higher number of amino acid residues than the protease from Bacillus pumilus according to SEQ ID NO:1. Based on the mentioned positions in the amino acid sequence of the protease from Bacillus pumilusThe change positions in a protease according to the invention are those that are assigned to these positions in an alignment.

[0054] Advantageous positions for sequence modifications, especially substitutions, of the protease from Bacillus pumilus, The positions that are preferably important when transferred to homologous positions of the proteases according to the invention and that confer advantageous functional properties on the protease are therefore the positions that correspond in an alignment to the positions described herein, i.e., in the numbering according to SEQ ID NO:1. The aforementioned positions are located in the wild-type molecule of the protease. Bacillus pumilus the following amino acid residues: P9, A18, A29, A48, F61, A92, N99, D101, N130, G131, T133, N137, N144, V149, S156, T159, T162, G166, D172, A192, S199, S216, Y217, S224, N252, K265 and Q271.

[0055] Further confirmation of the correct assignment of the amino acids to be modified, i.e., in particular their functional correspondence, can be provided by comparative experiments in which the two positions assigned to each other based on an alignment are modified in the same way in both proteases being compared, and it is observed whether the enzymatic activity is altered in the same way in both. For example, if an amino acid substitution at a specific position of the protease results in Bacillus pumilus If, according to SEQ ID NO:1, a change in an enzymatic parameter is associated, for example, with an increase in the KM value, and a corresponding change in the enzymatic parameter, for example, also an increase in the KM value, is observed in a protease variant according to the invention, whose amino acid exchange was achieved by the same introduced amino acid, then this is to be seen as confirmation of the correct assignment.

[0056] All of the above applies to the processes according to the invention for the production of a protease. Accordingly, a process according to the invention further comprises one or more of the following process steps: a) Introducing a single or multiple conservative amino acid substitution into the protease, wherein the protease (a) at the position corresponding to position 271, the amino acid substitution 271E; and (b) at the position corresponding to position 9, an amino acid substitution selected from 9T, 9H, 9S and 9A, preferably 9T; and (c1) at at least one of the positions corresponding to positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217 or 265, at least one further amino acid substitution selected from 18D, 61Y, 92S, 99Y, 137K, 149I, 156G, 156Y, 159I, 162S, 166M, 172G, 172P, 192V, 199M, 217M and 265A;and / or (c2) at least three of the positions corresponding to positions 29, 48, 101, 130, 131, 133, 144, 217, 224 and 252, in particular 130, 133, 144, 217 and 252, comprising at least three further amino acid substitutions selected from A29G, A48V, D101E, N130D, N130S, N130H, G131D, G131N, G131S, G131K, T133K, T133R, T133Y, N144K, N144L, N144A, S224A, S224T and N252S; b) Modification of the amino acid sequence by fragmentation, deletion, insertion or substitution mutagenesis such that the protease comprises an amino acid sequence that is identical to the original molecule over a length of at least 200, 210, 220, 230, 240, 250, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273 or 274 contiguous amino acids, wherein the protease (a) at the position corresponding to position 271 incorporates the amino acid substitution 271E;and (b) at the position corresponding to position 9, an amino acid substitution selected from 9T, 9H, 9S and 9A, preferably 9T; and (c1) at at least one of the positions corresponding to positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217 or 265, at least one further amino acid substitution selected from 18D, 61Y, 92S, 99Y, 137K, 149I, 156G, 156Y, 159I, 162S, 166M, 172G, 172P, 192V, 199M, 217M and 265A; and / or (b2) at least three of the positions corresponding to positions 29, 48, 101, 130, 131, 133, 144, 217, 224 and 252, in particular 130, 133, 144, 217 and 252, comprise at least three further amino acid substitutions selected from A29G, A48V, D101E, N130D, N130S, N130H, G131D, G131N, G131S, G131K, T133K, T133R, T133Y, N144K, N144L, N144A, S224A, S224T and N252S.

[0057] All embodiments also apply to the methods according to the invention. In particular, each of the aforementioned proteases can additionally comprise an amino acid substitution at position 216 and / or 217 in the numbering according to SEQ ID NO:1, especially 216C and / or 217M. However, in various embodiments, it may be preferred that the protease does not have a substitution at position 216.

[0058] In further embodiments of the invention, the protease or the protease produced by a process according to the invention is still at least 90%, 90.5%, 91%, 91.5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5%, or 98.8% identical to the amino acid sequence specified in SEQ ID NO:1 over its total length. Alternatively, the protease or the protease produced by a process according to the invention is still at least 90%, 90.5%, 91%, 91.5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5%, or 98.8% identical to one of the amino acid sequences specified in SEQ ID Nos:3-12, 16-25 over their total length.The protease, or the protease produced by a process according to the invention, has an amino acid substitution at position 271, in particular 271E, and (i) at position 9 and at least one of the positions corresponding to positions 29, 48, 101, 130, 131, 133, 144, 224 or 252, in particular one or more of the amino acid substitutions 9T, 130D, 144K and 252T, in each case based on the numbering according to SEQ ID NO:1, and / or (ii) at least one further amino acid substitution at at least one of the positions corresponding to positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217 or 265, in each case based on the Numbering according to SEQ ID NO:1, on.

[0059] In preferred embodiments, the amino acid substitution is at least one selected from the group consisting of P9T, P9H, P9T, P9A, A29G, A48V, D101E, N130D, N130S, N130H, G131D, G131N, G131S, G131K, T133K, T133R, T133Y, N144K, N144L, N144A, S224A, S224T, N252S and Q271E, each with reference to the numbering according to SEQ ID NO:1.

[0060] Examples of amino acid substitution variants include: P9T, P9H, P9S or P9A, especially P9T, and Q271E and optionally S216C combined with one of (I) A48V, G131S, T133R and S224A; (II) G131D, T133R and S224A; (III) N130D, G131N, T133K and N144K; (IV) A29G, N130D, G131N and T133R; (V) N130D, G131S, T133K and S224A; (VI) N130D, G131N, T133K, N144L and N252S; (VII) G131S, N144K and S224T; (VIII) N130S, G131S, T133Y, N144L and S224A; (IX) D101E, G131N and S224A; or (X) N130H, G131S and S224A, the numbering in each case being based on the numbering according to SEQ ID NO:1.

[0061] In various embodiments, the invention relates to proteases according to SEQ ID NO:1 with the following amino acid substitution variants: Q271E combined with one of (i) P9T, N130D, N144K and N252T; (ii) P9T, N130D, N144K, N252T and S156G; (iii) P9T, N130D, N144K, N252T and S156Y; (iv) P9T, N130D, N144K, N252T and Y217M; (v) P9T, N130D, N144K, N252T and N137K; (vi) N130D, N144K, N252T, P9H, A18D and T159I; or (vii) P9T and D172G, where the numbering is based on the numbering according to SEQ ID NO:1. Further examples are the variants described above and in the examples.

[0062] Another aspect of the invention is a previously described protease that is additionally stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer. Increased stability during storage and / or use, for example during the washing process, results in longer-lasting enzymatic activity and thus improved cleaning performance. In principle, all stabilization methods described in the prior art and / or deemed suitable are eligible. Stabilization achieved through mutations of the enzyme itself is preferred, as such stabilization does not require any further processing steps after enzyme production. Examples of suitable sequence modifications are mentioned above. Further suitable sequence modifications are known from the prior art.

[0063] Other stabilization options include, for example: Alteration of the binding of metal ions, especially the calcium binding sites, for example by exchanging one or more of the amino acid(s) involved in the calcium binding for one or more negatively charged amino acids and / or by introducing sequence changes in at least one of the sequences of the two amino acids arginine / glycine; protection against the influence of denaturing agents such as surfactants by mutations that cause a change in the amino acid sequence on or at the surface of the protein; exchange of amino acids located near the N-terminus for those that presumably interact with the rest of the molecule via non-covalent interactions and thus contribute to maintaining the globular structure.

[0064] Preferred embodiments are those in which the enzyme is stabilized in several ways, since multiple stabilizing mutations act additively or synergistically.

[0065] Another aspect of the invention is a protease as described above, characterized in that it has at least one chemical modification. A protease with such a modification is called a derivative, i.e., the protease is derivatized.

[0066] For the purposes of this application, derivatives are understood to be proteins whose pure amino acid chain has been chemically modified. Such derivatizations can, for example, in life Derivatization occurs through the host cell that expresses the protein. In this regard, couplings of low-molecular-weight compounds such as lipids or oligosaccharides are particularly noteworthy. However, derivatizations can also occur. in vitroDerivatization can be carried out, for example, by the chemical modification of a side chain of an amino acid or by covalently binding another compound to the protein. For instance, coupling amines to carboxyl groups of an enzyme is possible to alter the isoelectric point. Such another compound can also be a further protein, which is bound to a protein according to the invention, for example, via bifunctional chemical bonds. Similarly, derivatization can be understood as covalent binding to a macromolecular support or non-covalent inclusion in suitable macromolecular cage structures. Derivatizations can, for example, influence the substrate specificity or the binding strength to the substrate, or bring about a temporary blockage of enzymatic activity if the coupled substance is an inhibitor. This can be useful, for example, during storage.Such modifications can also affect stability or enzymatic activity. Furthermore, they can serve to reduce the allergenicity and / or immunogenicity of the protein, thereby, for example, increasing its skin tolerance. For instance, coupling with macromolecular compounds, such as polyethylene glycol, can improve the protein's stability and / or skin tolerance.

[0067] Derivatives of a protein according to the invention can, in the broadest sense, also include preparations of these proteins. Depending on the method of extraction, processing, or preparation, a protein may be combined with various other substances, for example, from the culture of the producing microorganisms. A protein may also have been deliberately combined with other substances, for example, to increase its storage stability. Therefore, all preparations of a protein according to the invention are also considered to be in accordance with the invention. This is also independent of whether or not it actually exhibits this enzymatic activity in a particular preparation. It may be desirable for it to have no or only slight activity during storage and to only develop its enzymatic function at the time of use. This can be controlled, for example, by means of appropriate accompanying substances.In particular, the joint preparation of proteases with specific inhibitors is possible in this regard.

[0068] Among all the proteases or protease variants and / or derivatives described above, those whose catalytic activity corresponds to at least one of those of the proteases according to SEQ ID Nos: 3-12 and 16-25, and / or whose cleaning performance corresponds to at least one of those of the proteases according to SEQ ID Nos: 3-12 or 16-25, wherein the cleaning performance is determined in a washing system as described above.

[0069] Another object of the invention is a nucleic acid encoding a protease according to the invention, and a vector containing such a nucleic acid, in particular a cloning vector or an expression vector.

[0070] These can be DNA or RNA molecules. They can exist as a single strand, as a single strand complementary to that single strand, or as a double strand. Particularly in the case of DNA molecules, the sequences of both complementary strands must be considered in all three possible reading frames. Furthermore, it must be taken into account that different codons, i.e., base triplets, can code for the same amino acids, so that a specific amino acid sequence can be coded by several different nucleic acids. Due to this degeneracy of the genetic code, all nucleic acid sequences that can code for one of the proteases described above are included in this invention. The person skilled in the art is able to determine these nucleic acid sequences without doubt, since, despite the degeneracy of the genetic code, defined amino acids can be assigned to individual codons.Therefore, a person skilled in the art can easily determine the nucleic acids encoding an amino acid sequence based on that sequence. Furthermore, in nucleic acids according to the invention, one or more codons can be replaced by synonymous codons. This aspect relates in particular to the heterologous expression of the enzymes according to the invention. Every organism, for example, a host cell of a production strain, has a specific codon usage. Codon usage refers to the translation of the genetic code into amino acids by the respective organism. Bottlenecks in protein biosynthesis can occur if the number of codons on the nucleic acid corresponds to a comparatively small number of charged tRNA molecules in the organism. Although encoding the same amino acid, this leads to one codon being translated less efficiently in the organism than a synonymous codon that codes for the same amino acid.Due to the presence of a higher number of tRNA molecules for the synonymous codon, it can be translated more efficiently in the organism.

[0071] Using well-known methods such as chemical synthesis or polymerase chain reaction (PCR) in conjunction with standard molecular biological and / or protein chemistry techniques, a specialist can synthesize the corresponding nucleic acids, even complete genes, from known DNA and / or amino acid sequences. Such methods are described, for example, in Sambrook, J., Fritsch, EF and Maniatis, T. 2001. Molecular cloning: a laboratory manual, 3rd Edition Cold Spring Laboratory Press.

[0072] For the purposes of the present invention, vectors are understood to be elements consisting of nucleic acids that contain a nucleic acid according to the invention as their characteristic nucleic acid region. They are capable of establishing this nucleic acid as a stable genetic element in a species or cell line over several generations or cell divisions. Vectors are, in particular, special plasmids, i.e., circular genetic elements, when used in bacteria. Within the scope of the present invention, a nucleic acid according to the invention is cloned into a vector. Vectors include, for example, those originating from bacterial plasmids, viruses, or bacteriophages, or predominantly synthetic vectors or plasmids with elements of various origins. With the other genetic elements present, vectors are able to establish themselves as stable units in the respective host cells over several generations.They can exist extrachromosomally as separate units or be integrated into a chromosome or chromosomal DNA.

[0073] Expression vectors comprise nucleic acid sequences that enable them to replicate in the host cells containing them, preferably microorganisms, particularly preferably bacteria, and to induce the expression of a contained nucleic acid. Expression is influenced in particular by the promoter(s) that regulate transcription. In principle, expression can be effected by the natural promoter originally located upstream of the nucleic acid to be expressed, but also by a promoter of the host cell provided on the expression vector, or even by a modified or entirely different promoter from another organism or host cell. In the present case, at least one promoter is provided for the expression of a nucleic acid according to the invention and is used for its expression.Expression vectors can also be regulated, for example, by changing the cultivation conditions, by reaching a certain cell density of the host cells containing them, or by adding specific substances, particularly gene expression activators. An example of such a substance is the galactose derivative isopropyl β-D-thiogalactopyranoside (IPTG), which is used as an activator of the bacterial lactose operon (lac operon). In contrast to expression vectors, the nucleic acid contained in cloning vectors is not expressed.

[0074] Another object of the invention is a non-human host cell containing a nucleic acid or vector according to the invention, or containing a protease according to the invention, in particular one that secretes the protease into the medium surrounding the host cell. Preferably, a nucleic acid or vector according to the invention is transformed into a microorganism, which then constitutes a host cell according to the invention. Alternatively, individual components, i.e., nucleic acid parts or fragments, of a nucleic acid according to the invention can be introduced into a host cell such that the resulting host cell contains a nucleic acid or vector according to the invention.This approach is particularly suitable when the host cell already contains one or more components of a nucleic acid or vector according to the invention, and the other components are then added accordingly. Methods for cell transformation are well-established in the art and are well known to those skilled in the art. In principle, all cells are suitable as host cells, i.e., prokaryotic or eukaryotic cells. Host cells that are genetically advantageous to handle, for example, with regard to transformation with the nucleic acid or vector and its stable establishment, are preferred; for example, unicellular fungi or bacteria. Furthermore, preferred host cells are characterized by good microbiological and biotechnological handling.This includes, for example, ease of cultivation, high growth rates, low requirements for fermentation media, and good production and secretion rates for foreign proteins. Preferred host cells according to the invention secrete the (transgenically) expressed protein into the medium surrounding the host cells. Furthermore, the proteases can be modified by the cells that produce them after their synthesis, for example, by the attachment of sugar molecules, formylation, amination, etc. Such post-translational modifications can functionally influence the protease.

[0075] Further preferred embodiments include host cells whose activity can be regulated due to genetic regulatory elements, which may be provided on the vector or may already be present in these cells. For example, these elements can be stimulated to express the proteins by the controlled addition of chemical compounds acting as activators, by changing the cultivation conditions, or upon reaching a specific cell density. This enables the economical production of the proteins according to the invention. An example of such a compound is IPTG as described above.

[0076] Preferred host cells are prokaryotic or bacterial cells. Bacteria are characterized by short generation times and low requirements for cultivation conditions. This allows for the establishment of cost-effective cultivation or manufacturing processes. Furthermore, experts possess a wealth of experience with bacteria in fermentation technology. For a specific production, Gram-negative or Gram-positive bacteria may be suitable for a variety of reasons, which must be determined experimentally in each individual case, such as nutrient sources, product formation rate, time requirements, etc.

[0077] In gram-negative bacteria such as, for example Escherichia coliA large number of proteins are secreted into the periplasmic space, that is, into the compartment between the two cell membranes. This can be advantageous for specific applications. Furthermore, Gram-negative bacteria can also be modified to secrete expressed proteins not only into the periplasmic space but also into the surrounding medium. Gram-positive bacteria, such as bacilli or actinomycetes, or other representatives of the ActinomycetalesIn contrast, they lack an outer membrane, so secreted proteins are immediately released into the surrounding medium, usually the culture medium, from which the expressed proteins can be purified. They can be isolated directly from the medium or processed further. Furthermore, Gram-positive bacteria are related to or identical with most of the source organisms for technically important enzymes and usually produce comparable enzymes themselves, meaning they have similar codon usage and their protein synthesis machinery is naturally geared accordingly.

[0078] Host cells according to the invention may be modified with respect to their requirements for culture conditions, exhibit different or additional selection markers, or express other or additional proteins. In particular, they may also be host cells that transgenically express several proteins or enzymes.

[0079] The present invention is applicable in principle to all microorganisms, in particular to all fermentable microorganisms, especially preferably to those of the genus Bacillus, applicable and leads to the production of proteins according to the invention through the use of such microorganisms. Such microorganisms then constitute host cells within the meaning of the invention.

[0080] In a further embodiment of the invention, the host cell is characterized in that it is a bacterium, preferably one selected from the group of genera of Escherichia, Klebsiella, Bacillus, Staphylococcus, Corynebacterium, Arthrobacter, Streptomyces, Stenotrophomonas and Pseudomonas, further prefers one that is selected from the group of Escherichia coli, Klebsiella planticola, Bacillus licheniformis, Bacillus lentus, Bacillus amyloliquefaciens, Bacillus subtilis, Bacillus alcalophilus, Bacillus globigii, Bacillus gibsonii, Bacillus clausii, Bacillus halodurans, Bacillus pumilus, Staphylococcus carnosus, Corynebacterium glutamicum, Arthrobacter oxidans, Streptomyces lividans, Streptomyces coelicolor and Stenotrophomonas maltophilia.

[0081] The host cell can also be a eukaryotic cell, characterized by the presence of a nucleus. Therefore, another aspect of the invention is a host cell characterized by the presence of a nucleus. In contrast to prokaryotic cells, eukaryotic cells are able to post-translationally modify the protein they produce. Examples include fungi such as... Actinomycetes or yeasts such as Saccharomyces or Kluyveromyces.This can be particularly advantageous, for example, when proteins are to undergo specific modifications during their synthesis that enable such systems. Modifications that eukaryotic systems carry out, especially in connection with protein synthesis, include, for example, the binding of low-molecular-weight compounds such as membrane anchors or oligosaccharides. Such oligosaccharide modifications can be desirable, for instance, to reduce the allergenicity of an expressed protein. Co-expression with enzymes naturally produced by such cells, such as cellulases, can also be advantageous. Furthermore, thermophilic fungal expression systems, for example, can be particularly suitable for the expression of temperature-resistant proteins or variants.

[0082] The host cells according to the invention are cultivated and fermented in the usual manner, for example in batch or continuous systems. In the first case, a suitable nutrient medium is inoculated with the host cells, and the product is harvested from the medium after a period to be determined experimentally. Continuous fermentations are characterized by reaching a steady state in which cells partially die off but also regrow over a comparatively long period, and the protein produced can be simultaneously extracted from the medium.

[0083] Host cells according to the invention are preferably used to produce proteases according to the invention. A further aspect of the invention is therefore a method for producing a protease. a) Cultivating a host cell according to the invention, and b) isolating the protease from the culture medium or from the host cell.

[0084] This invention preferably comprises fermentation processes. Fermentation processes are known per se from the prior art and represent the actual large-scale production step, generally followed by a suitable purification method of the produced product, for example, the proteases according to the invention. All fermentation processes based on a corresponding process for producing a protease according to the invention represent embodiments of this invention.

[0085] Fermentation processes characterized by a feed-in strategy are particularly suitable. In this approach, the media components consumed during continuous cultivation are fed back in. This can lead to significant increases in cell density, cell mass (or dry mass), and / or, in particular, the activity of the protease of interest. Furthermore, the fermentation can be designed to filter out unwanted metabolic products or neutralize them by adding buffers or appropriate counterions.

[0086] The produced protease can be harvested from the fermentation medium. Such a fermentation method is preferable to isolating the protease from the host cell, i.e., preparing the product from the cell mass (dry mass). However, it requires the provision of suitable host cells or one or more suitable secretion markers or mechanisms and / or transport systems so that the host cells secrete the protease into the fermentation medium. Alternatively, without secretion, the protease can be isolated from the host cell, i.e., purified from the cell mass, for example, by precipitation with ammonium sulfate or ethanol, or by chromatographic purification.

[0087] All the above-mentioned facts can be combined to form processes for producing proteases according to the invention.

[0088] Another aspect of the invention is a composition characterized in that it contains a protease according to the invention as described above. Preferably, the composition is used as a washing or cleaning agent.

[0089] This invention encompasses all conceivable types of washing or cleaning agents, both concentrates and undiluted products, for use on a commercial scale, in washing machines, or for hand washing or cleaning. This includes, for example, detergents for textiles, carpets, or natural fibers, for which the term "detergent" is used. It also includes, for example, dishwashing liquids for dishwashers or manual dishwashing liquids, or cleaners for hard surfaces such as metal, glass, porcelain, ceramics, tiles, stone, painted surfaces, plastics, wood, or leather, for which the term "cleaning agent" is used. This includes, in addition to manual and machine dishwashing liquids, for example, scouring agents, glass cleaners, toilet fresheners, etc.The washing and cleaning agents within the scope of the invention also include washing aids that are added to the actual detergent during manual or machine washing of textiles to achieve an additional effect. Furthermore, washing and cleaning agents within the scope of the invention also include textile pre- and post-treatment agents, i.e., agents with which the garment is brought into contact before the actual washing, for example, to loosen stubborn stains, and also agents that, in a step following the actual washing process, impart further desirable properties to the laundry, such as a pleasant feel, wrinkle resistance, or low static charge. Fabric softeners are among the latter types of agents.

[0090] The washing or cleaning agents according to the invention, which can be in the form of powdered solids, compacted particles, homogeneous solutions, or suspensions, can contain, in addition to a protease according to the invention, all known ingredients commonly used in such agents, preferably including at least one further ingredient. The agents according to the invention can, in particular, contain surfactants, builders, peroxygen compounds, or bleach activators. Furthermore, they can contain water-miscible organic solvents, further enzymes, sequestrants, electrolytes, pH regulators, and / or further additives such as optical brighteners, anti-graying agents, foam regulators, as well as dyes and fragrances, and combinations thereof.

[0091] In particular, a combination of a protease according to the invention with one or more further ingredients of the composition is advantageous, since such a composition, in preferred embodiments according to the invention, exhibits improved cleaning performance due to resulting synergism. Such synergism can be achieved, in particular, by combining a protease according to the invention with a surfactant and / or a builder and / or a peroxygen compound and / or a bleach activator. However, in preferred embodiments, the composition according to the invention may not contain boric acid.

[0092] Advantageous ingredients of the composition according to the invention are disclosed in the international patent application WO2009 / 121725, beginning on page 5, penultimate paragraph, and ending on page 13 after the second paragraph.

[0093] An agent according to the invention advantageously contains the protease in an amount of 2 µg to 20 mg, preferably 5 µg to 17.5 mg, particularly preferably 20 µg to 15 mg, and most preferably 50 µg to 10 mg per gram of the agent. In various embodiments, the concentration of the protease (active enzyme) described herein in the agent is >0 to 1 wt.%, preferably 0.001 to 0.1 wt.% based on the total weight of the agent or composition. Furthermore, the protease contained in the agent, and / or other ingredients of the agent, can be encapsulated with a substance that is impermeable to the enzyme at room temperature or in the absence of water, but which becomes permeable to the enzyme under the conditions of use of the agent. Such an embodiment of the invention is thus characterized in that the protease is encapsulated with a substance that is impermeable to the protease at room temperature or in the absence of water.Furthermore, the washing or cleaning agent itself can also be packaged in a container, preferably an air-permeable container, from which it is released shortly before use or during the washing process.

[0094] In further embodiments of the invention, the means is characterized in that it (a) is in solid form, in particular as a free-flowing powder with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l, or (b) is in pasty or liquid form, and / or (c) is in gel or pouch form, and / or (d) is a single-component system, or (e) is divided into several components.

[0095] These embodiments of the present invention encompass all solid, powdered, liquid, gel-like, or pasty dosage forms of the composition according to the invention, which may optionally consist of several phases and be in compressed or uncompressed form. The composition may be in the form of a free-flowing powder, in particular with a bulk density of 300 g / l to 1200 g / l, more specifically 500 g / l to 900 g / l or 600 g / l to 850 g / l. Solid dosage forms of the composition also include extrudates, granules, tablets, or pouches. Alternatively, the composition may also be liquid, gel-like, or pasty, for example, in the form of a non-aqueous liquid detergent or a non-aqueous paste, or in the form of an aqueous liquid detergent or an aqueous paste. Furthermore, the composition may be in the form of a single-component system. Such compositions consist of one phase. Alternatively, a composition may also consist of several phases.Such a remedy is therefore divided into several components.

[0096] Washing or cleaning agents according to the invention can contain only one protease. Alternatively, they can also contain other hydrolytic enzymes or other enzymes in a concentration suitable for the efficacy of the agent. A further embodiment of the invention thus comprises agents that additionally include one or more further enzymes. Preferably used as further enzymes are all enzymes that can exhibit catalytic activity in the agent according to the invention, in particular lipase, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, xyloglucanase, β-glucosidase, pectinase, carrageenase, perhydrolase, oxidase, oxidoreductase, or other proteases—distinguishable from the proteases according to the invention—as well as mixtures thereof. Advantageously, further enzymes are each contained in the agent in an amount of 1 x 10⁻⁸ to 5% by weight based on active protein.Increasingly preferably, each further enzyme is contained in the composition according to the invention in an amount of 1 x 10⁻⁷ to 3 wt.%, 0.00001 to 1 wt.%, 0.00005 to 0.5 wt.%, 0.0001 to 0.1 wt.%, and particularly preferably 0.0001 to 0.05 wt.%, based on active protein. The enzymes particularly preferably exhibit synergistic cleaning performance against certain soils or stains, i.e., the enzymes contained in the composition mutually support each other in their cleaning performance. Such synergism is most preferably present between the protease contained in the composition according to the invention and another enzyme of a composition according to the invention, including, in particular, between the aforementioned protease and an amylase and / or a lipase and / or a mannanase and / or a cellulase and / or a pectinase.Synergistic effects can occur not only between different enzymes, but also between one or more enzymes and other ingredients of the agent according to the invention.

[0097] In the cleaning agents described herein, the enzymes to be used may also be formulated together with accompanying substances, for example from fermentation. In liquid formulations, the enzymes are preferably used as liquid enzyme formulation(s).

[0098] Enzymes are generally not supplied in the form of pure protein, but rather in the form of stabilized preparations that are suitable for storage and transport. These pre-prepared formulations include, for example, solid preparations obtained by granulation, extrusion, or lyophilization, or, particularly in the case of liquid or gel-like agents, solutions of the enzymes, advantageously as concentrated as possible, with a low water content, and / or containing stabilizers or other additives.

[0099] Alternatively, the enzymes can be encapsulated for both solid and liquid dosage forms, for example, by spray drying or extrusion of the enzyme solution together with a preferably natural polymer, or in the form of capsules, such as those in which the enzymes are enclosed as if in a solidified gel, or in core-shell type capsules in which an enzyme-containing core is coated with a protective layer impermeable to water, air, and / or chemicals. Additional active ingredients, such as stabilizers, emulsifiers, pigments, bleaching agents, or dyes, can be applied in superimposed layers. Such capsules are produced using methods known per se, for example, by shake or roll granulation or in fluid-bed processes. Advantageously, such granules are low-dust, for example, due to the application of polymeric film formers, and have a long shelf life due to the coating.

[0100] Furthermore, it is possible to combine two or more enzymes so that a single granule has multiple enzyme activities.

[0101] The enzymes can also be incorporated into water-soluble films, such as those used in the formulation of unit-dose detergents and cleaning agents. Such a film allows the enzymes to be released upon contact with water. As used herein, "water-soluble" refers to a film structure that is preferably completely water-soluble. Preferably, such a film consists of (fully or partially hydrolyzed) polyvinyl alcohol (PVA).

[0102] Another object of the invention is a method for cleaning textiles or hard surfaces, characterized in that an agent according to the invention is used in at least one process step, or that a protease according to the invention becomes catalytically active in at least one process step, in particular in such a way that the protease is used in an amount of 40µg to 4g, preferably 50µg to 3g, particularly preferably 100µg to 2g and most preferably 200µg to 1g.

[0103] In various embodiments, the above-described method is characterized by the fact that the protease is used at a temperature of 0 to 100°C, preferably 0 to 60°C, more preferably 20 to 40°C and most preferably at 20°C or 25°C.

[0104] This includes both manual and machine-based methods, with machine-based methods being preferred. Methods for cleaning textiles are generally characterized by the fact that, in several process steps, various cleaning agents are applied to the item being cleaned and rinsed off after the contact time, or that the item being cleaned is otherwise treated with a detergent or a solution or dilution thereof. The same applies to methods for cleaning all materials other than textiles, in particular hard surfaces. All conceivable washing or cleaning methods can be enhanced in at least one of the process steps by the application of a detergent or cleaning agent or a protease according to the invention, and then represent embodiments of the present invention.All facts, objects, and embodiments described for the protease and the means containing it according to the invention are also applicable to this subject matter of the invention. Therefore, explicit reference is made here to the disclosure at the relevant point, with the note that this disclosure also applies to the aforementioned methods according to the invention.

[0105] Since proteases according to the invention naturally possess hydrolytic activity and exhibit this activity even in media that otherwise lack cleaning power, such as simple buffer, a single and / or the only step of such a process can consist of bringing a protease according to the invention into contact with the soiling as the sole cleaning-active component, preferably in a buffer solution or in water. This represents a further embodiment of this invention.

[0106] Alternative embodiments of this invention also include processes for treating textile raw materials or for textile care, in which a protease according to the invention is activated in at least one process step. Processes for textile raw materials, fibers, or textiles with natural components are preferred, and especially for those containing wool or silk.

[0107] Finally, the invention also encompasses the use of the proteases described herein in washing or cleaning agents, for example as described above, for the (improved) removal of protein-containing soils, for example from textiles or hard surfaces. In various embodiments of this use, the protease is stored in the washing or cleaning agent for 3 or more days, 4 or more days, 7 or more days, 10 or more days, 12 or more days, 14 or more days, 21 or more days, or 28 or more days prior to a washing or cleaning process.

[0108] All circumstances, objects, and embodiments described for the protease and the means containing it according to the invention are also applicable to this subject matter of the invention. Therefore, explicit reference is made here to the disclosure at the relevant point, with the note that this disclosure also applies to the aforementioned use according to the invention. Examples Übersicht über die Mutationen:

[0109] This invention relates to an alkaline protease of the subtilisin type composed of Bacillus pumilus. This protease (wild type) Bacillus pumilusVariants of the DSM18097 protease (SEQ ID NO:1) were generated by random mutagenesis and then screened for, among other things, improved washing performance and / or enzyme stability. In this way, two performance-enhancing mutants (mutant 1 [SEQ ID NO:13] and mutant 2 [SEQ ID NO:2]) were generated from the aforementioned wild-type protease (SEQ ID NO:1) in a first round of error prone mutagenesis. An independent second round of error prone mutagenesis was then applied to both of these mutants. In this second round of mutations, mutants 3-12 (SEQ ID Nos. 3-12) were generated. Therefore, all mutants 3-12 mentioned here also carry at least some of the mutations of mutants 1 or 2. In a third round, further performance-enhanced mutants (mutant 1 [SEQ ID NO:14], mutant 2 [SEQ ID NO:15], mutant 3 [SEQ ID NO: 16]) were generated through error prone mutagenesis. These mutants then underwent another error prone round (4th round).In this fourth round of mutations, mutants 16-24 were generated according to SEQ ID Nos. 17-25, as well as mutants 25-52. Variant Aminosäuresubstitutionen relativ zu SEQ ID NO:1 SEQ ID NO: Mutant 1 P9T Q271E S216C 13 Mutant 2 P9T Q271E S216C T133R S224A 2 Mutant 3 P9T Q271E S216C A48V G131S T133R S224A 3 Mutant 4 P9T Q271E S216C G131D T133R S224A 4 Mutant 5 P9T Q271E S216C N130D G131N T133K N144K 5 Mutant 6 P9T Q271E S216C A29G N130D G131N T133R 6 Mutant 7 P9T Q271E S216C N130D G131S T131K S224A 7 Mutant 8 P9T Q271E S216C N130D G131N T133K N144L N252S 8 Mutant 9 P9T Q271E S216C G131S N144K S224T 9 Mutant 10 P9T Q271E S216C N130S G131S T133Y N144L S224A 10 Mutant 11 P9T Q271E S216C D101E G131N S224A 11 Mutant 12 P9T Q271E S216C N130H G131S S224A 12 Mutant 13 P9T Q271E 14 Mutant 14 N130D N144K N252T Q271E 15 Mutant 15 P9T N130D N144K N252T Q271E 16 Mutant 16 P9T N130D N144K N252T Q271E S156G 17 Mutant 17 P9T N130D N144K N252T Q271E S156Y 18 Mutant 18 P9T N130D N144K N252T Q271E Y217M 19 Mutant 19 P9T N130D N144K N252T Q271E N137K 20 Mutant 20 N130D N144K N252T Q271E F61Y A92S 21 Mutant 21 N130D N144K N252T Q271E T162S 22 Mutant 22 N130D N144K N252T Q271E A192V 23 Mutant 23 P9H N130D N144K N252T Q271E A18D T159I 24 Mutant 24 P9T Q271E D172G 25 Mutant 25 P9T N130D N144K N252T Q271E T133R Mutant 26 P9T N130D N144K N252T Q271E T133K Mutant 27 P9T N130D N144K N252T Q271E S224A Mutant 28 P9T N130D N144K N252T Q271E S224A T133R Mutant 29 P9T N130D N144K N252T Q271E D172G Mutant 30 P9T N130D N144K N252T Q271E D172P Mutant 31 P9T N130D N144K N252T Q271E V149I Mutant 32 P9T N130D N144K N252T Q271E N99Y Mutant 33 P9T N130D N144K N252T Q271E Q62S Mutant 34 P9T N130D N144K N252T Q271E N137K Mutant 35 P9T N130D N144K N252T Q271E T162S Mutant 36 P9T N130D N144K N252T Q271E Y217M T133R Mutant 37 P9T N130D N144K N252T Q271E Y217M Mutant 38 P9T N130D N144K N252T Q271E Y217M T133A Mutant 39 P9T N130D N144K N252T Q271E Y217M A192V Mutant 40 P9T N130D N144K N252T Q271E T133A A192V Mutant 41 P9T N130D N144K N252T Q271E T162S A192V Mutant 42 P9T N130D N144K N252T Q271E T162S Y217M Mutant 43 P9T N130D N144K N252T Q271E T162S T133A Mutant 44 P9T N130D N144K N252T Q271E T162S Y217M A192V Mutant 45 P9T N130D N144K N252T Q271E T162S Y217M A192V T133A Mutant 46 P9T N130D N144K N252T Q271E T162S Y217M T133A Mutant 47 P9T N130D N144K N252T Q271E T162S A192V T133A Mutant 48 P9T N130D N144K N252T Q271E T133A K265A Mutant 49 P9T N130D N144K N252T Q271E T133A S199M Mutant 50 P9T N130D N144K N252T Q271E T133A G166M Mutant 51 P9T N130D N144K N252T Q271E T162S G166M Mutant 52 P9T N130D N144K N252T Q271E A192V Detergent matrix used

[0110] The following detergent matrices (commercially available, without enzymes, optical brighteners, perfume and dyes) were used for the washing tests: Washing test 2: Chemical name % wt% active substance in the raw material wt% active substance in the formulation Demineralized water. 100 rest Alkylbenzenesulfonic acid 96 12-18 Anionic surfactants 70 4-8 C12-C18 fatty acid sodium salt 30 2-4 Non-ionic surfactants 100 8-14 Phosphonate 60 0,5-2 citric acid 100 3-5 NaOH 50 0,5-2 Defoamer 100 <1% Glycerin 99,5 1-3 1,2-Propanediol 100 8-12 Monoethanolamine 100 4-8 Soil repellent polymer 30 0,5-1 Protease stabilizer 100 0,5-1,5 Without optical brighteners, perfume, dye and enzymes. Dosage 3.17 g / L Wash test 1: Chemical name % wt% active substance in the raw material wt% active substance in the formulation Demineralized water. 100 rest Alkylbenzenesulfonic acid 96 4,4 Anionic surfactants 70 5,6 C12-C18 fatty acid sodium salt 30 2,4 Non-ionic surfactants 100 4,4 Phosphonates 40 0,2 citric acid 100 1,4 NaOH 50 0,95 Defoamer tq 0,01 Glycerin 100 2 preservatives 100 0,08 Ethanol 93 1 Without optical brighteners, perfume, dye and enzymes. Dosage 4.7 g / L Protease activity assays

[0111] The activity of the protease is determined by the release of the chromophore para-nitroaniline from the substrate succinyl alanine-alanine-proline-phenylalanine-para-nitroanilide (AAPFpNA; Bachem L-1400). The release of pNA causes an increase in absorbance at 410 nm, the time course of which is a measure of the enzymatic activity.

[0112] The measurement was performed at a temperature of 25°C, a pH of 8.6, and a wavelength of 410 nm. The measurement time was 5 minutes with a measurement interval of 20 to 60 seconds. Measurement approach:

[0113] 10 µL AAPF solution (70 mg / mL) 1000 µL Tris / HCl (0.1 M; pH 8.6 with 0.1% Brij 35) 10 µL diluted protease solution Kinetics generated over 5 minutes at 25°C (410 nm) Mini wash test and results Wash test 1:

[0114] Wash test with Bacillus subtilis Culture supernatants containing the screened protease mutants via heterologous expression. The supernatants were treated with an activity equivalent to the benchmark (starting molecules) for this mutagenesis round (mutants 1 and 2 according to SEQ ID Nos. 1 and 2) at a commercially available concentration for proteases in detergents. Conditions: 40°C, 16°dH water, 1 h Soiling:

[0115] 1. CFT CS038 2. CFT PC-10 3. WfK 10N 4. CFT C-03 5. EMPA 112 6. CFT C-05

[0116] Place die-cut tissue samples (diameter = 10 mm) in a microtiter plate, pre-temper the washing solution to 40°C, final concentration 4.7 g / L, add the solution and enzyme to the soiling, incubate for 1 h at 40°C and 600 rpm, then rinse the soiling several times with clean water, allow to dry, and determine the brightness using a colorimeter. The lighter the fabric becomes, the better the cleaning performance. The L-value (brightness) was measured here; the higher the value, the lighter the soiling. The sum of the 6 soiling samples is given as a percentage relative to the mutant according to SEQ ID NO:13 or the mutant according to SEQ ID NO:2. variant Catalytic activity (referring to cat. activity of mutant 2 (SEQ ID NO:2)) 40°C 20°C Mutant 2 100% 100% Mutant 3 112% 117% Mutant 4 112% 110%

[0117] Both variants show increased washing performance compared to the original variant (mutant 2 according to SEQ ID NO:2). The improvements are evident at 40°C and 20°C. variant Catalytic activity (referring to cat. activity of mutant 1 (SEQ ID NO: 13)) 40°C 20°C Mutant 1 100% 100% Mutant 5 129% 138% Mutant 6 113% 148% Mutant 7 129% 124% Mutant 8 126% 121% Mutant 9 134% 117% Mutant 10 118% 124% Mutant 11 118% 117% Mutant 12 121% 131%

[0118] All variants show increased washing performance compared to the original variant (mutant 1 according to SEQ ID NO:13). The improvements are evident at 40°C and 20°C. Wash test 2:

[0119] Wash test with Bacillus subtilis Culture supernatants containing the screened protease mutants via heterologous expression. The supernatants are used at a commercially available concentration for proteases in detergents, with activity levels equivalent to the benchmark (wild type, according to SEQ ID NO:1). All mutants are calibrated to the cleaning performance of the wild type, which is set to 100% (sum of the 7 soils, corrected for the detergent's performance alone). Conditions: 40°C, 16°dH water, 1 h Soiling:

[0120] 1. CFT CS038 2. CFT PC-10 3. WfK 10N 4. CFT C-03 5. EMPA 112 6. CFT C-05 7. H-MR-B

[0121] Die-cut tissue samples (diameter = 10 mm) were placed in microtiter plates. The washing solution was pre-tempered to 40°C, with a final concentration of 3.17 g / L. The solution and enzyme were applied to the soiled area and incubated for 1 hour at 40°C and 600 rpm. The soiled area was then rinsed several times with clean water, allowed to dry, and its brightness was measured using a colorimeter. The lighter the fabric became, the better the cleaning performance. The L-value (brightness) was measured; the higher the value, the lighter the stain. The total value of the seven soiled areas is given as a percentage relative to the wild type according to SEQ ID NO:1, corrected for the performance of the detergent without protease. variant Performance in the washing test at 40°C (based on wild type performance (SEQ ID NO:1)) Wild type 100% Mutant 13 103% Mutant 15 105% Mutant 16 109% Mutant 17 110% Mutant 18 106,5% Mutant 19 106% Mutant 20 113% Mutant 21 109% Mutant 22 107,5% Mutant 23 101,5% Mutant 24 101,5%

[0122] All variants show increased washing performance compared to the wild type according to SEQ ID NO:1.

[0123] The same wash test was performed again at 20°C, using mutant 3 as a reference. variant Performance in the washing test at 20°C (referring to the performance of Mutant 3 (SEQ ID NO:4)) Mutant 15 100% Mutant 25 105% Mutant 26 107% Mutant 27 107% Mutant 28 113%

[0124] Another wash test was carried out as described above at 40°C with the soiling CFT PC-10, using mutant 15 as a reference. variant Performance in the washing test at 40°C (referring to the performance of Mutant 3 (SEQ ID NO:4)) Mutant 15 100% Mutant 29 117% Mutant 30 118% Mutant 31 108% Mutant 32 108% Mutant 33 117% Mutant 34 121% Mutant 35 116% Mutant 36 118% Mutant 37 122%

[0125] All variants showed increased washing performance compared to the variant according to SEQ ID NO:16.

Claims

1. A protease comprising an amino acid sequence which has at least 90% sequence identity with the amino acid sequence specified in SEQ ID NO:1 over its entire length and in each case relative to the numbering according to SEQ ID NO:1: (a) at the position corresponding to position 271, the amino acid substitution Q271E; and (b) at the position corresponding to position 9, an amino acid substitution selected from P9T, P9H, P9S and P9A, preferably P9T; and (c1) at at least one of the positions corresponding to positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217 or 265, at least one further amino acid substitution selected from A18D, F61Y, A92S, N99Y, N137K, V149I, S156G, S156Y, T159I, T162S, G166M, D172G, D172P, A192V, S199M, Y217M and K265A; and / or (c2)at at least three of the positions corresponding to positions 29, 48, 101, 130, 131, 133, 144, 217, 224 and 252, in particular 130, 133, 144, 217 and 252, at least three further amino acid substitutions selected from A29G, A48V, D101E, N130D, N130S, N130H, G131D, G131N, G131S, G131K, T133K, T133R, T133Y, N144K, N144L, N144A, S224A, S224T, N252S and N252T.

2. The protease according to claim 1, comprising an amino acid sequence which has at least 90% sequence identity with the amino acid sequence specified in SEQ ID NO:1 over the entire length thereof and in each case relative to the numbering according to SEQ ID NO:1: (a) at the position corresponding to position 271, the amino acid substitution Q271E; and (b) at the position corresponding to position 9, an amino acid substitution selected from P9T, P9H, P9S and P9A, preferably P9T; and (c2)at at least three of the positions corresponding to positions 29, 48, 101, 130, 131, 133, 144, 224 and 252, in particular 130, 133, 144 and 252, at least three further amino acid substitutions, selected from A29G, A48V, D101E, N130D, N130S, N130H, G131D, G131N, G131S, G131K, T133K, T133R, T133Y, N144K, N144L, N144A, S224A, S224T, N252S and N252T.

3. The protease according to claim 1, comprising an amino acid sequence which has at least 90% sequence identity with the amino acid sequence specified in SEQ ID NO:1 over the entire length thereof and in each case relative to the numbering according to SEQ ID NO:1: (a) at the position corresponding to position 271, the amino acid substitution Q271E; and (b) at the position corresponding to position 9, the amino acid substitution P9T; and (c1) at at least one of the positions corresponding to positions 18, 61, 92, 99, 137, 149, 156, 159, 162, 166, 172, 192, 199, 217 or 265, at least one amino acid substitution selected from A18D, F61Y, A92S, N99Y, N137K, V149I, S156G, S156Y, T159I, T162S, G166M, D172G, D172P, A192V, S199M, Y217M and K265A; and (c2) at the positions corresponding to positions 130, 144 and 252, the amino acid substitutions N130D, N144K and N252T.

4. The protease according to claim 1, wherein the protease comprises amino acid substitutions (1) at the positions corresponding to positions 9 and 271 and at least one of 130, 131, 133 and 224, in each case based on the numbering according to SEQ ID NO:1, and (2) optionally at at least one of the positions corresponding to positions 29, 48, 101, 144 and 252, in each case in relation to the numbering according to SEQ ID NO:1.

5. The protease according to any one of the preceding claims, wherein the protease comprises one of the following amino acid substitution variants, in each case based on the numbering according to SEQ ID NO:1: P9T, P9H, P9S or P9A, in particular P9T, and Q271E and optionally S216C and additionally one of (i) A48V, G131S, T133R and S224A; (ii) G131D, T133R and S224A; (iii) N130D, G131N, T133Kand N144K; (iv) A29G, N130D, G131N and T133R; (v) N130D, G131S, T133K and S224A; (vi) N130D, G131N, T133K, N144L and N252S; (vii) G131S, N144K and S224T; (viii) N130S, G131S, T133Y, N144L and S224A; (ix) D101E, G131N and S224A; or (x) N130H, G131S and S224A.

6. The protease according to any one of claims 1-3, wherein the protease has (1) at the positions corresponding to positions 9, 130, 144, 252 and 271, the amino acid substitutions P9T, N130D, N144K, N252T and Q271E; and (2) at least one further amino acid substitution at at least one of the positions corresponding to positions 62, 99, 133, 137, 149, 156, 162, 166, 172, 192, 199, 217, 224 or 265.

7. The protease according to claim 1 or 3, wherein the protease has (1) at the positions corresponding to positions 9 and 271, the amino acid substitutions P9T and Q271E; and (2) at least one further amino acid substitution at the position corresponding to position 172.

8. The protease according to any one of the preceding claims, wherein the protease comprises one of the following amino acid substitution variants, in each case based on the numbering according to SEQ ID NO:1: Q271E and additionally one of (i) P9T, N130D, N144K and N252T; (ii) P9T, N130D, N144K, S156G and N252T; (iii) P9T, N130D, N144K, S156Y and N252T; (iv) P9T, N130D, N144K, Y217M and N252T; (v) P9T, N130D, N137K, N144K and N252T; (vi) P9H, A18D, N130D, N144K, T159I and N252T; or (vii) P9T and D172G.

9. The protease according to any one of the preceding claims, wherein the protease has an amino acid sequence according to any one of SEQ ID Nos. 3-12 and 16-25.

10. A nucleic acid encoding a protease according to any one of claims 1-9.

11. A vector comprising a nucleic acid according to claim 10, in particular a cloning vector or an expression vector.

12. A non-human host cell comprising a nucleic acid according to claim 11 or a vector according to claim 14, or comprising a protease according to any one of claims 1-9.

13. Method for the preparation of a protease comprising a) culturing a host cell according to claim 12; and b) Isolation of the protease from the culture medium or from the host cell.

14. Agent, in particular a washing or cleaning agent, characterized in that it contains at least one protease according to one of claims 1-9.

15. Method for cleaning textiles or hard surfaces, characterized in that an agent according to claim 14 is used in at least one method step, or in that a protease according to one of claims 1-9 is used in at least one method step.

16. Use of a protease according to any one of claims 1-9 in a washing or cleaning agent for removing peptide- or protein-containing soiling.